BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 11526998)

  • 1. A neurobiological basis for substance abuse comorbidity in schizophrenia.
    Chambers RA; Krystal JH; Self DW
    Biol Psychiatry; 2001 Jul; 50(2):71-83. PubMed ID: 11526998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
    Awad AG
    J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic circuitry and risk/reward decision making: implications for schizophrenia.
    Stopper CM; Floresco SB
    Schizophr Bull; 2015 Jan; 41(1):9-14. PubMed ID: 25406370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):269-76. PubMed ID: 19834992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role of hippocampal dysfunction in schizophrenic symptomatology.
    Luchins DJ
    Biol Psychiatry; 1990 Jul; 28(2):87-91. PubMed ID: 2378923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.
    Chambers RA; Self DW
    Neuropsychopharmacology; 2002 Dec; 27(6):889-905. PubMed ID: 12464446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia.
    Brady AM; Saul RD; Wiest MK
    Neuropharmacology; 2010 Dec; 59(7-8):605-11. PubMed ID: 20732335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.
    Salamone JD; Correa M; Farrar A; Mingote SM
    Psychopharmacology (Berl); 2007 Apr; 191(3):461-82. PubMed ID: 17225164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expected value and prediction error abnormalities in depression and schizophrenia.
    Gradin VB; Kumar P; Waiter G; Ahearn T; Stickle C; Milders M; Reid I; Hall J; Steele JD
    Brain; 2011 Jun; 134(Pt 6):1751-64. PubMed ID: 21482548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.
    Jentsch JD; Taylor JR
    Psychopharmacology (Berl); 1999 Oct; 146(4):373-90. PubMed ID: 10550488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia and substance abuse.
    Selzer JA; Lieberman JA
    Psychiatr Clin North Am; 1993 Jun; 16(2):401-12. PubMed ID: 8332568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports.
    Dixon L; Haas G; Weiden P; Sweeney J; Frances A
    Schizophr Bull; 1990; 16(1):69-79. PubMed ID: 2185536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse and schizophrenia: editors' introduction.
    Kosten TR; Ziedonis DM
    Schizophr Bull; 1997; 23(2):181-6. PubMed ID: 9165628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia: from developmental deviance to dopamine dysregulation.
    Murray RM; Lappin J; Di Forti M
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S129-34. PubMed ID: 18499406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.